Announcement under Regulation 30 (LODR)-Press Release / Media Release
'Zydus receives final approval from the USFDA for Baclofen Tablets'27-11-2018
27-11-2018
Zydus Cadila gets USFDA nod for generic cholesterol drug
Atorvastatin is used along with a proper diet to help lower bad cholesterol and fats and raise good cholesterol (HDL) in the blood.22-11-2018
Announcement under Regulation 30 (LODR)-Press Release / Media Release
Zydus receives approvals from the USFDA for Atorvastatin Calcium Tablets and Dimethyl Fumarate Delayed-Release Capsules22-11-2018
Announcement under Regulation 30 (LODR)-Press Release / Media Release
Please find enclosed a copy of press release dated November 20, 2018 titled 'Zydus receives tentative approval from the USFDA for Deferasirox Tablets'.20-11-2018
Announcement under Regulation 30 (LODR)-Press Release / Media Release
Please find enclosed a copy of press release dated November 16, 2018 titled 'Zydus receives final approval from the USFDA for Abacavir & Lamivudine Tablets and Fondaparinux Sodium Injection'.16-11-2018
Zydus Cadila gets USFDA nod for leukemia injection
Zydus Cadila on Wednesday said it has received approval from the US health regulator to market Arsenic Trioxide injection, used to treat a type of le14-11-2018
Announcement under Regulation 30 (LODR)-Press Release / Media Release
Please find enclosed a copy of press release dated November 14, 2018 titled 'Zydus receives final approval from the USFDA for Arsenic Trioxide Injection'.14-11-2018
Clarification
The Exchange had sought clarification from Cadila Healthcare Ltd with reference to the media report, "Kerala regulator finds three drugs to be of substandard quality" The Company response is enclosed.12-11-2018
Clarification sought from Cadila Healthcare Ltd
The Exchange has sought clarification from Cadila Healthcare Ltd with respect to news article appearing on indianexpress.com - November 11, 2018 titled "Kerala regulator finds three drugs to be of substandard quality".The reply is awaited.12-11-2018
Zydus Cadila gets USFDA nod for anti-fungal ointment
Zydus Cadila has received final approval from the US health regulator to market Nystatin and Triamcinolone Acetonide ointment, used in the treatment12-11-2018